Ki-67 is strongly prognostic in synovial sarcoma: Analysis based on 86 patients from the Scandinavian Sarcoma Group Register

British Journal of Cancer

Volumn 80, Issue 11, 1999, Pages 1809-1814

  Skytting, B T ^a   Bauer, H C ^b   Perfekt, R ^d   Nilsson, G ^c   Larsson, O ^c  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b Department of Orthopedics   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ki 67; Multivariate analysis; Prognosis; Synovial sarcoma

Indexed keywords

FORMALDEHYDE; KI 67 ANTIGEN; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SYNOVIAL SARCOMA; TISSUE FIXATION; TUMOR VOLUME;

ANTIGENS, NUCLEAR; BIOLOGICAL MARKERS; CELL NUCLEUS; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; HUMANS; KI-67 ANTIGEN; MITOTIC INDEX; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SARCOMA, SYNOVIAL; SCANDINAVIA; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032810563     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690602     Document Type: Article

References (31)

1. Angervall L, Kindblom L-G, Rydholm A and Stener B (1986) The diagnosis and prognosis of soft tissue tumors. Semin Diagn Pathol 3: 240-258
2. Broders AC and Hargrave R (1939) Pathologic features of soft tissue fibrosatcoma. Surg Gynecol Obstet 69: 267-280
3. Brodsky JT, Burt ME, Hajdu SI, Casper ES and Brennan MF (1992) Tendosynovial sarcoma. Clinicopathologic features, treatment, and prognosis. Cancer 70: 484-489
4. Brown DC and Gatter KC (1990) Monoclonal antibody Ki-67; its use in histopathology. Histopathology 17: 489-503
5. Cadman NL, Soule EH and Kelly PJ (1965) Synovial sarcoma. Cancer 18: 613-623
6. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J and Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363
7. Choong PFM, Åkerman M, Willen H, Andersson C, Gustafson P, Baldetorp B, Fernö M, Alvegärd T and Rydholm A (1994) Prognostic value of Ki-67 expression in 182 soft issue sarcomas. Proliferation a marker of metastasis? APMIS 102: 915-924
8. Choong PFM, Pritchard DJ, Sim FH, Rock MG and Nascimento AG (1995) Long-term survival in high grade soft tissue sarcoma; prognostic factors in synovial sarcoma. Int J Oncol 7: 161-169
9. Cordon Cardo C, Latres E, Drobnjak M, Oliva MR, Pollak D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ (1994) Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799
10. Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, De Mascarel A and Goussot JF (1986) Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58: 306-309
11. Drobnjak M, Latres E, Pollak D, Karpeh M, Dudas M, Woodruff JM, Brennan MF and Cordon-Cardo C (1994) Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas. J Natl Cancer Inst 86: 549-554
12. Enzinger FM and Weiss SW (1995) Soft Tissue Tumours Mosby: St Louis
13. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M and Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8: 531-539
14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U and Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715
15. Gerdes J, Becker MHG and Key G (1992) Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 168: 85-87
16. Hajdu SI, Shui MH and Fortner JG (1977) Tendosynovial sarcoma. Cancer 39: 1201-1217
17. Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM and Brennan MF (1998) Ki-67 detected by MIB 1 predicts distant metastasis and tumour mortality in primary, high grade extremity soft tissue sarcoma. Cancer 83: 490-497
18. Kalbfleisch JD and Prentice RL (1980) The Stistical Analysis of Failure Time Data. Wiley: New York
19. Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H and Fukuma H (1994) Nuclear immunoreaction of p53 protein in soft tissue sarcomas. Cancer 73: 2499-2505
20. Levine EA, Holzmayer T, Bacus S, Mechelner E, Mera R, Bolliger C, Roninson IB and Das Gupka TK (1997) Evaluation of newer prognostic markers for adult soft tissue sarcoma. J Clin Oncol 15: 3249-3257
21. Limon J, Mrozek K, Mandahl N, Nedoszytko B. Verhest A and Rys J (1991) Cytogenetics of synovial sarcoma: presentation of ten new cases and review of the literature. Genes Chromosomes Cancer 3: 338-345
22. Meis-Kindblom JM and Kindblom L-G (1998) Angiosarcoma in soft tissue: a study of 80 cases. Am J Surg Pathol 6: 683-697
23. Nakanishi H, Ohsawa M, Naka N, Uchida A, Ochi T and Aozasa K (1997) Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis. Oncology 54: 238-244
24. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostettef R, Cleary K, Bigner SH, Davidson N, Baylin S and Devilee P (1986) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
25. Raycroft L, Wu HY and Lozano G (1990) Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249: 1049-1051
26. Shi R-R, Key ME and Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. Histochem J 39: 741-748
27. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y and Yamamuro T (1993) P53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 68: 1134-1139
28. Wright PH, Sim FH, Soule EH and Taylor WF (1982) Synovial sarcoma. J Bone Joint Surg 64-A: 112-122
29. Wurl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen H-J, Schmidt H, Kalthoff H, Rath F-W and Dralle H (1987) Prognostic value of immunohistochemistry for p53 in primary soft tissue sarcomas: a multivariate analysis of five antibodies. J Cancer Res Oncol 123: 502-508
30. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948
31. Zehr RJ, Bauer TW, Marks KE and Weltevreden A (1990) Ki-67 and grading of malignant fibrous histocytomas. Cancer 66: 1984-1990